swine
influenza
infecti
diseas
caus
rna
virus
highli
contagi
multipl
strain
viru
common
throughout
pig
popul
worldwid
caus
signific
econom
loss
industri
least
three
swiv
subtyp
current
circul
swine
popul
despit
regular
vaccin
exchang
influenza
virus
human
swine
common
oneway
street
tradit
vaccin
less
effect
possibl
includ
strain
activ
infect
peopl
world
therefor
therapeut
altern
prevent
infect
maintain
health
livestock
highli
warrant
probiot
defin
live
microorgan
administ
adequ
amount
confer
health
benefit
host
faowho
although
target
intestin
tract
probiot
also
affect
mucos
defenc
gener
includ
immun
respons
respiratori
tissu
probiot
bacteria
part
gut
microflora
report
promot
host
defens
modul
immun
system
probiot
recent
shown
mediat
antivir
effect
certain
virus
vitro
vivo
effect
variou
strain
probiot
cours
viru
infect
pig
studi
intens
howev
descript
inform
effect
probiot
model
virus
vesicular
stomat
viru
vsv
transmiss
gastroenter
viru
tgev
rotavirus
avail
data
yet
avail
swine
influenza
virus
import
view
exquisit
zoonot
capac
commonli
believ
mammalian
influenza
virus
restrict
respiratori
tissu
thu
may
hardli
affect
probiot
act
intestin
howev
recent
report
pathogenesi
season
influenza
viru
ferret
show
viru
also
present
intestin
furthermor
world
acknowledg
avian
influenza
virus
frequent
infect
intestin
avian
host
therefor
appear
justifi
includ
influenza
virus
studi
probiot
inhibit
viru
multipl
vitro
vivo
enterococcu
faecium
ncimb
author
eu
safe
use
probiot
feed
addit
therefor
repres
suitabl
probiot
studi
possibl
antivir
properti
previous
carri
experi
probiot
context
bacteri
infect
show
e
faecium
modul
intestin
immun
piglet
present
studi
explor
e
faecium
affect
replic
swine
influenza
viru
macrophag
epitheli
cell
line
mdbk
cytotox
e
faecium
mdbk
cell
shown
fig
compar
control
cell
cell
surviv
rate
applic
e
faecium
examin
cell
line
lead
detriment
effect
cell
integr
metabol
unless
concentr
exceed
concentr
cfuml
seen
result
compil
fig
e
faecium
concentr
cfuml
sever
cytotox
effect
especi
macrophag
cell
line
condit
proport
mdbkcell
still
surviv
presenc
probiot
base
result
cfuml
e
faecium
appli
interfer
studi
describ
expect
cytotox
studi
cfuml
e
faecium
affect
viabil
uninfect
mdbk
cell
fig
first
two
bar
cell
type
swiv
hpi
destroy
cell
monolay
complet
defin
surviv
shown
treatment
modal
concentr
e
faecium
result
protect
cell
swiv
infect
among
setup
competit
probiot
bacteria
swivinoculum
ad
monolay
togeth
min
result
protect
effect
protect
effect
mdbk
cell
even
pretreat
cell
e
faecium
addit
probiot
complet
swivinfect
result
signific
rescu
cell
death
swivinfect
grey
horizont
mark
bar
fig
result
confirm
anoth
viabil
assay
pi
stain
dead
cell
measur
flow
cytometri
data
shown
effect
e
faecium
treatment
viral
titer
valid
assay
shown
fig
viru
titer
decreas
significantli
treatment
type
host
cell
e
faecium
degre
inhibit
differ
depend
whether
probiot
present
infect
swiv
reduct
obtain
e
faecium
swiv
present
monolay
simultan
indic
direct
competit
swiv
probiot
present
unknown
entiti
result
effect
inhibit
viru
product
see
h
period
swiv
quantifi
growth
medium
result
line
cell
viabil
assay
swivinfect
cell
treat
nontreat
probiot
shown
fig
qualit
probiot
induc
inhibit
swiv
appear
type
host
cell
appear
somewhat
effect
macrophag
line
howev
could
also
due
lower
swivtit
reach
nontreat
mdbkcell
one
logunit
less
nontreat
known
literatur
besid
multipl
function
nitric
oxid
import
physiolog
messeng
effector
molecul
antivir
effect
assess
secret
influenc
e
faecium
reveal
signific
stimul
effect
cell
shown
fig
e
faecium
increas
product
noninfect
bar
right
side
swivinfect
cell
first
three
bar
result
shown
strongest
stimul
reach
e
faecium
ad
host
cell
simultan
viru
competit
white
bar
mdbkcell
stimul
much
less
pronounc
howev
result
shown
fig
indic
tendenc
signific
probiot
induc
stimul
noninfect
cell
possibl
influenza
viru
particl
could
engag
direct
physic
interact
probiot
bacteria
may
lead
loss
infect
address
question
includ
experi
viru
particl
mix
probiot
bacteria
test
tube
incub
h
room
temperatur
preincub
low
speed
centrifug
mixtur
sediment
e
faecium
bacteriumfre
supernat
titrat
infecti
swiv
assay
seen
data
tabl
viru
titer
reduc
two
logunit
type
host
cell
viru
bound
bacteri
cell
preincub
period
present
bacteri
sediment
centrifug
step
probe
possibl
bacteri
sediment
subject
real
timequantit
pcr
primer
swiv
mprotein
appli
result
find
input
viru
detect
bacteri
sediment
data
shown
shown
tabl
swiv
supernat
low
speed
centrifug
lost
infect
significantli
mdbkcell
howev
measur
cultur
increas
record
cell
type
observ
inhibit
viru
multipl
stimul
experi
probiot
ad
cell
swiv
play
viru
enter
cell
fig
fig
indic
e
faecium
may
influenc
cellular
factor
affect
viru
growth
therefor
analys
cell
express
cytokin
ifn
known
potenti
modul
viru
product
result
quantit
rtpcr
shown
fig
reveal
decreas
express
mediat
compar
nontreat
sampl
swivinfect
without
e
faecium
hand
immunosuppress
cytokin
show
low
express
h
increas
strongli
h
h
probiotictr
cultur
fig
furthermor
e
faecium
promot
increas
express
h
h
h
post
swiv
infect
although
without
signific
valu
viru
group
e
faecium
treat
group
effect
regard
tendenc
probiot
microorgan
mainli
studi
context
bacteri
infect
gastrointestin
tract
natur
target
tissu
probiot
howev
report
indic
upon
oral
intak
probiot
also
affect
infect
respiratori
tract
also
report
literatur
probiot
induc
antivir
activ
vitro
even
appli
medic
treatment
persist
viru
infect
human
anim
chose
zoonot
swine
influenza
virus
novel
studi
object
test
antivir
potenti
probiot
e
faecium
elucid
mechan
action
present
result
vitro
experi
use
porcin
viru
mdbk
cell
respect
result
demonstr
probiot
e
faecium
effect
protect
host
cell
swine
influenza
viru
infect
support
author
hypothesi
probiot
use
inhibit
enter
virus
may
also
potenti
control
respiratori
virus
two
differ
swiv
strain
chosen
current
circul
pig
popul
establish
model
present
vitro
studi
epitheli
mdbkcell
porcin
alveolar
macrophag
cell
line
util
argu
concentr
probiot
util
may
reflect
situat
target
tissu
vivo
howev
concentr
chosen
treatment
cell
cultur
cfuml
reflect
concentr
determin
gut
piglet
fed
e
faecium
supplement
previou
feed
trial
research
consortium
order
find
period
swiv
replic
cycl
probiot
stringent
effect
e
faecium
ad
brief
period
time
min
host
cell
either
viru
infect
fig
result
indic
simultan
addit
viru
e
faecium
host
cell
monolay
effect
time
inhibit
viru
multipl
shown
fig
fig
experiment
setup
term
competit
result
logunit
reduct
viru
titer
concomit
rescu
cell
viabil
sinc
h
exposur
monolay
e
faecium
swivinfect
h
treatment
complet
viru
infect
also
led
logunit
loss
viru
titer
probiot
must
alter
host
cell
factor
appar
result
inhibit
influenza
viru
multipl
obviou
candid
factor
mediat
cellular
defenc
process
express
subsequ
increas
activ
previous
report
play
role
host
respons
multipl
viral
famili
variou
host
speci
addit
antivir
properti
describ
modul
intestin
barrier
function
gut
motil
iron
transport
implic
numer
infect
noninfecti
diseas
intestin
found
e
faecium
increas
express
mdbk
cell
fig
sampl
collect
treatment
e
faecium
show
significantli
increas
novalu
compar
nontreat
counterpart
cell
line
consist
hypothesi
high
level
associ
decreas
viru
product
addit
stimul
noreleas
probiot
could
also
affect
express
cytokin
immun
mediat
relev
innat
immun
respons
viral
infect
therefor
determin
express
select
mediat
swivinfect
host
cell
seen
fig
e
faecium
promot
increas
express
sinc
differ
valu
nontreat
e
faecium
treat
cell
found
nonsignific
rule
main
immunoregulatori
cytokin
could
lead
e
faecium
induc
inhibit
swivinfect
anoth
cytokin
stimul
probiot
treatment
typic
cytokin
initi
repress
viru
infect
cell
express
higher
level
later
infect
control
initi
inflammatori
respons
infect
interestingli
cytokin
clearli
enhanc
macrophag
cell
line
upon
e
faecium
treatment
thu
could
support
cellular
control
swiv
infect
two
proinflammatori
cytokin
found
clearli
reduc
swivinfect
treat
probiot
secret
macrophag
known
play
indirect
immunoregulatori
role
immun
respons
viral
infect
act
inflammatori
cytokin
trigger
cascad
cytokin
product
sinc
downregul
e
faecium
swivinfect
cell
reduc
inflammatori
respons
caus
cytokin
cellular
level
may
contribut
antivir
effect
probiot
tolllik
receptor
first
identifi
antivir
tlr
central
role
host
respons
virus
experiment
data
show
treatment
swivinfect
e
faecium
led
decreas
express
h
h
post
infect
compar
viru
alon
suggest
probiot
induc
modul
receptor
may
role
antivir
function
e
faecium
sinc
e
faecium
act
inhibitori
ad
togeth
viru
particl
assess
whether
swiv
might
physic
trap
inactiv
probiot
bacteria
mix
incub
detail
preincub
assay
experiment
design
shown
fig
lower
panel
result
summar
tabl
show
substanti
portion
input
viru
particl
inde
trap
bacteria
sinc
viru
infect
lost
supernat
viral
genom
equival
detect
bacteri
sediment
low
speed
centrifug
incub
mixtur
data
shown
thu
experiment
condit
two
antivir
function
probiot
may
oper
synergist
add
produc
sever
inhibit
swiv
result
present
altogeth
show
probiot
e
faecium
quit
effect
inhibit
multipl
swine
influenza
virus
relev
cell
cultur
system
antivir
mechan
probiot
probabl
manifold
sinc
found
act
viru
particl
host
cell
howev
least
inhibitori
paramet
could
identifi
e
faecium
bacteria
abl
adsorb
swivparticl
alert
cell
mediat
rapid
antivir
respons
modul
express
defenc
relev
mediat
amongst
identifi
entiti
modul
probiot
treatment
realiz
e
faecium
induc
much
complex
reaction
treat
tissu
sinc
mediat
could
assess
studi
one
common
denomin
probiot
action
could
mediat
affect
mani
cellular
signal
cascad
line
public
virushost
cell
system
result
point
central
role
stimul
upon
treatment
probiot
may
mount
improv
cellular
defenc
respons
swivinfect
tissu
stimul
probiot
base
vitro
data
shown
porcin
influenza
viru
hypothes
use
e
faecium
probiot
feed
food
addit
potenti
reduc
influenza
viru
infect
mammalian
tissu
swiv
challeng
experi
piglet
fed
e
faecium
supplement
present
progress
order
test
hypothesi
swiv
strain
madindarbi
bovin
kidney
mdbk
cell
use
studi
gener
gift
dr
r
impfstoffwerk
dessauthornau
germani
stock
viru
propag
mdbk
mdck
cell
respect
strain
use
mdbk
cell
strain
use
macrophag
mdbk
mdck
cell
maintain
dulbecco
modifi
eagl
medium
dmem
pan
biotech
supplement
fetal
calf
serum
hyclon
penicillinstreptomycin
biochrom
porcin
continu
monomyeloid
cell
line
establish
primari
porcin
alveolar
macrophag
kindli
provid
prof
univers
maribor
slovenia
dr
hana
weingartl
cell
maintain
advanc
dulbecco
modifi
eagl
medium
gibco
supplement
fetal
calf
serum
hyclon
penicillinstreptomycin
biochrom
e
faecium
ncimb
cerbiospharma
sa
maintain
toddhewitt
broth
roth
experi
done
triplic
determin
possibl
cytotox
effect
e
faecium
differ
concentr
coloni
form
unit
cfu
ml
ad
mdbk
cell
monolay
plate
greiner
bioon
h
cell
viabil
monitor
methylthiazolyldiphenyltetrazolium
bromid
mtt
viabil
assay
briefli
cell
monolay
wash
h
treatment
period
mtt
pb
ad
well
plate
incub
incub
h
solubilis
formazan
crystal
form
period
achiev
addit
dmso
solut
absorb
od
nm
measur
use
micropl
reader
tecan
germani
cell
surviv
rate
determin
bacteria
averag
od
valuecontrol
averag
od
valu
interfer
studi
infect
cell
strain
swiv
done
multipl
infect
moi
e
faecium
appli
concentr
cfuml
avoid
carri
effect
e
faecium
wash
two
time
penicillinstreptomycin
use
stop
propag
e
faecium
schemat
fig
depict
experiment
setup
studi
interfer
e
faecium
swivinfect
two
cell
cultur
system
allow
us
defin
time
viru
growth
addit
probiot
effect
preincub
setup
reveal
whether
probiot
bacteria
direct
effect
viru
particl
without
involv
host
cell
mtt
assay
use
measur
mitochondri
function
serv
viabil
index
metabol
activ
cell
experiment
incub
period
mtt
assay
appli
describ
percentag
metabol
activ
cell
treat
probiot
bacteria
percentag
protect
cytopath
effect
achiev
calcul
data
repres
averag
valu
minimum
six
well
three
independ
experi
viru
titer
calcul
tissu
cultur
infecti
dose
titrat
supernat
contain
swiv
tenfold
step
cell
mdbk
indic
cell
respect
three
day
infect
indic
cell
stain
giemsa
sigma
cytopath
effect
cpe
observ
macroscop
microscop
result
assay
calcul
accord
reed
muench
method
releas
determin
measur
amount
releas
cultur
medium
use
griessassay
promega
accord
manufactur
instruct
briefli
experiment
sampl
transfer
well
plate
triplic
defin
standard
sampl
assess
parallel
produc
standard
curv
sulfanilamid
solut
sulfanilamid
phosphor
acid
ad
well
minut
room
temperatur
ned
solut
dispens
room
temperatur
minut
absorb
od
nm
measur
use
micropl
reader
tecan
releas
sampl
calcul
use
nitrit
standard
curv
gener
parallel
investig
viru
could
trap
probiot
e
faecium
cfuml
mix
moi
swiv
total
ml
dmem
min
coincub
incub
h
mixtur
centrifug
rpm
min
compar
fig
preincub
assay
sediment
prepar
quantit
pcr
supernat
use
infect
cell
total
rna
isol
sediment
protein
swiv
amplifi
compar
viru
control
viru
titer
releas
assay
mention
carri
hpi
variou
treatment
period
cell
collect
well
h
h
h
total
rna
isol
cell
sampl
use
gene
matrix
rna
purif
kit
eurx
revers
transcript
rt
perform
use
revertaidtm
first
strand
cdna
synthesi
kit
fermenta
accord
manufactur
instruct
pcr
reaction
perform
total
volum
icycl
iq
detect
system
biorad
laboratori
express
gene
analyz
use
rel
quantif
method
design
gene
primer
sequenc
anneal
temperatur
size
amplif
list
tabl
calcul
perform
ibm
spss
data
analysi
viru
titer
releas
perform
two
factori
anova
follow
post
hoc
test
scheff
data
analysi
cytokin
express
perform
pair
two
tail
ttest
p
valu
consid
statist
signific
p
valu
consid
statist
signific
data
given
mean
standard
deviat
